CGTX Company Profile and Key Details

Q: Who are the executives of CGTX?

Dr. Steven A. Weissman Ph.D.Vice President & Head of CMCDr. Anthony O. Caggiano M.D., Ph.D.Chief Medical Officer and Head of R&DMs. Lisa RicciardiChief Executive Officer, Pres & DirectorMr. Andrew J. Einhorn CPAInterim Chief Financial OfficerMr. John Brendan DoyleChief Financial Officer

NASDAQ : CGTX

Cognition Therapeutics

$1.09

0.02000005+1.87%

At Close 4:00 PM

73.63

A-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Cognition Therapeutics, Inc. (CGTX) stock surged +1.87%, trading at $1.09 on NASDAQ, up from the previous close of $1.07. The stock opened at $1.07, fluctuating between $1.03 and $1.10 in the recent session.

Stock Snapshot

1.07

Prev. Close

80.2M

Market Cap

1.03

Day Low

-4.54

P/E Ratio

-0.24

EPS (TTM)

-0.53

Cash Flow per Share

1.07

Open

73.58M

Number of Shares

1.1

Day High

80.37%

Free Float in %

0.8

Book Value

1.98M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 09, 2026	1.05	1.10	1.03	1.09	1.98M
Jul 08, 2026	1.06	1.08	1.00	1.07	2.57M
Jul 07, 2026	1.05	1.13	1.01	1.08	1.95M
Jul 06, 2026	1.14	1.18	1.06	1.07	2.62M
Jul 02, 2026	1.15	1.21	1.13	1.17	2.05M
Jul 01, 2026	1.18	1.22	1.11	1.13	2.36M
Jun 30, 2026	1.09	1.19	1.09	1.15	869.72K
Jun 29, 2026	1.11	1.14	1.05	1.09	1.82M
Jun 26, 2026	1.10	1.20	1.08	1.12	3.49M
Jun 25, 2026	1.07	1.22	0.93	1.13	3.91M
Jun 24, 2026	1.56	1.61	0.97	1.02	11.81M
Jun 23, 2026	1.62	1.75	1.55	1.65	1.33M
Jun 22, 2026	1.46	1.76	1.45	1.68	4.05M
Jun 18, 2026	1.48	1.50	1.39	1.45	1.3M
Jun 17, 2026	1.29	1.48	1.25	1.42	2.33M
Jun 16, 2026	1.22	1.30	1.19	1.26	1.08M
Jun 15, 2026	1.26	1.30	1.21	1.21	860.35K
Jun 12, 2026	1.21	1.23	1.19	1.21	454.31K
Jun 11, 2026	1.14	1.22	1.13	1.20	600.09K
Jun 10, 2026	1.12	1.21	1.12	1.14	486.03K

Contact Details

Purchase, NY 10577

United States

https://www.cogrx.com 412 481 2210

About Company

Cognition Therapeutics, Inc. is a biopharmaceutical company in the clinical stage, focused on identifying and advancing small molecule treatments. The firm's research and development efforts are primarily directed towards age-related neurodegenerative conditions affecting the central nervous system, as well as retinal disorders. Its most advanced experimental therapy is CT1812, which acts as a sigma-2 receptor antagonist. This compound is currently being evaluated in Phase II clinical trials for the management of mild-to-moderate Alzheimer's disease and dementia with Lewy bodies (DLB). Additionally, it has successfully concluded Phase I trials for early-stage Alzheimer's and is undergoing preclinical investigation for dry age-related macular degeneration (AMD). The company's pipeline also includes CT2168, a treatment candidate for synucleinopathies—a category of diseases encompassing DLB and Parkinson's disease—and CT2074, which is in development for dry AMD. Cognition Therapeutics, Inc. was established in 2007 and operates from its headquarters in Purchase, New York.

Stock Peers

ARGX

-5.81-0.63%

argenx SE$909.49 REGN

5.07+0.76%

Regeneron Pharmaceuticals, Inc.$667.95 MDGL

-5.39-0.95%

Madrigal Pharmaceuticals, Inc.$560.01 UTHR

-1.86-0.34%

United Therapeutics Corporation$552.48 VRTX

-1.93001-0.39%

Vertex Pharmaceuticals Incorporated$496.50 KRYS

-4.15999-1.11%

Krystal Biotech, Inc.$371.24 PRAX

0.13+0.04%

Praxis Precision Medicines, Inc.$333.12 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

7.73+2.45%

Ligand Pharmaceuticals Incorporated$322.61 ALNY

-10.70999-3.31%

Alnylam Pharmaceuticals, Inc.$312.79

Frequently Asked Questions

What is the current Cognition Therapeutics, Inc. (CGTX) stock price?

Cognition Therapeutics, Inc. (NASDAQ: CGTX) stock price is $1.09 in the last trading session. During the trading session, CGTX stock reached the peak price of $1.10 while $1.03 was the lowest point it dropped to. The percentage change in CGTX stock occurred in the recent session was 1.87% while the dollar amount for the price change in CGTX stock was $0.02.

CGTX's industry and sector of operation?

The NASDAQ listed CGTX is part of Biotechnology industry that operates in the broader Healthcare sector. Cognition Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CGTX?

Dr. Steven A. Weissman Ph.D.
Vice President & Head of CMC
Dr. Anthony O. Caggiano M.D., Ph.D.
Chief Medical Officer and Head of R&D
Ms. Lisa Ricciardi
Chief Executive Officer, Pres & Director
Mr. Andrew J. Einhorn CPA
Interim Chief Financial Officer
Mr. John Brendan Doyle
Chief Financial Officer

How CGTX did perform over past 52-week?

CGTX's closing price is 98.18% higher than its 52-week low of $0.55 where as its distance from 52-week high of $3.83 is -71.54%.

How many employees does CGTX have?

Number of CGTX employees currently stands at 25.

Link for CGTX official website?

Official Website of CGTX is: https://www.cogrx.com

How do I contact CGTX?

CGTX could be contacted at phone 412 481 2210 and can also be accessed through its website. CGTX operates from 2500 Westchester Avenue, Purchase, NY 10577, United States.

How many shares of CGTX are traded daily?

CGTX stock volume for the day was 1.98M shares. The average number of CGTX shares traded daily for last 3 months was 1.51M.

What is the market cap of CGTX currently?

The market value of CGTX currently stands at $80.20M with its latest stock price at $1.09 and 73.58M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	25
Beta	1.75
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	25
Beta	1.75
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

CGTX Company Profile and Key Details

Cognition Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Shareholding & Insider Activity

Valuation Metrics

Price Forecast & Outlook

Key Takeaways